Pharming’s Portfolio Grows As Ultra-Rare Disease Drug Joenja Is Approved

Priced At $547,500 Per Year

 
• By Andrew McConaghie
  
Rare disease people
Pharming will provide free genetic testing to help diagnose patients with the ultra-rare condition. • Source: Shutterstocks
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Business

More from Scrip